Nisa Leung

Nisa Leung (Chinese:梁颕宇or梁颖宇) bụ onye na-achụ ego na onye njikwa na Qiming Venture Partners . Akpọrọ ya aha na Forbes Midas List afọ ise na-esochi na 2019, 2020, 2021,2022 na 2023.      na Best Women Venture Capitalists nke Forbes China afọ atọ.    A kpọkwara Nisa otu n'ime ụmụ nwanyị kachasị ike na azụmaahịa na China site na Fortune China na 2022 na 2023.  A maara Nisa nke ọma dị ka onye na-ebute ego na ahụike China.    

 Agụmakwụkwọ 
Nisa nwetara nzere bachelọ nke sayensị na Mahadum Cornell wee were MBA gụsịrị akwụkwọ na Stanford Graduate School of Business na 2001.

 Ọrụ 
Nisa malitere ọrụ ya na ntinye ego ahụike mgbe ọ chọpụtara na enweghi ọgwụgwọ ọgwụgwọ dị elu na China mgbe ezinụlọ ya na-achọ ọgwụgwọ maka nwanne nna ya dị anya, bụ onye a chọpụtara na ọ nwere ọrịa cancer imeju.  

Tupu isonyere Qiming Venture Partners na 2006, o mebere Biomedic Holdings, nke nwere ọrụ na itinye ego na ngwaọrụ ahụike, ọgwụ na ọrụ nlekọta ahụike na China gụnyere Novamed Pharmaceuticals (nke SciClone NASDAQ nwetara: SCLN) na U-Systems (enwetara. site na GE Healthcare). Ọ bụkwa onye mmekọ Venture nke PacRim Ventures na Menlo Park ma soro ya na Softbank/Mobius Venture Capital na mbụ. 

Na-eduga itinye ego nlekọta ahụike Qiming, Nisa akwadola ihe fọrọ nke nta ka ọ bụrụ ụlọ ọrụ nlekọta ahụike 200.  Ọ na-anọdụ ugbu a na bọọdụ Zai Lab (NASDAQ: ZLAB; HKSE: 9688), CanSino Biologics (SSE: 688185; HKSE: 6185), Caidya, Chain Medical Labs, Belief BioMed, Zencore Biologics, Valgen MedTech, Alamar Biosciences n'etiti ndị ọzọ. . Ntinye ego ya ndị ọzọ gụnyere Gan & Lee (SSE: 603087), New Horizon Health (HKSE: 6606), Berry Genomics (SZSE: 000710), CITIC Pharma (nke Shanghai Pharmaceutical HKSE nwetara: 2607), Crown Bioscience (nke JSR Life Sciences nwetara), Aeonmed Medical, Novast Pharmaceuticals, Nurotron, Origene Teknụzụ (nke VCAN Bio SSE nwetara: 600645), Richen, Vision Pro, MEDx, Cure Genetics, Goodwill (SSE: 688246), SinoCellTech (SSE: 688520), Sino Biological (SZSE: 3001) ), Apollomics (NASDAQ:APLM), SinoUnited Health, Schrödinger (NASDAQ: SDGR), Recursion (NASDAQ: RXRX), Insilico Medicine, Structure Therapeutics (NASDAQ: GPCR), Jacobio (HKSE: 1167), Hope Medicine, Sinotau, PlusLife n'etiti ndị ọzọ. 

 Ntụaka 
akwadola ihe fọrọ nke nta ka ọ bụrụ ụlọ ọrụ nlekọta ahụike 200. [1] Ọ na-anọdụ ugbu a na bọọdụ
Òtù:Mmadụ ndi di ndụ